Table 1. Comparisons of clinicopathologic features by ureteroenteric stricture status.

Variable	No UES (N=2,093)	UES (N=192)	Total (N=2,285)	P value
Male gender, no. [%]	1,701 [81]	158 [82]	1,859 [81]	0.73
Age, yr. [median; IQR]	68.0 [61.0–75.0]	69.0 [63.0–75.0]	68.0 [62.0–75.0]	0.21
BMI, median [IQR]	26.9 [24.3–30.0]	28.3 [25.6–31.6]	27.0 [24.4–30.1]	0.0001
ECOG, no. [%]				0.24
0	1,652 [80]	158 [83]	1,810 [80]
1	309 [15]	28 [15]	337 [15]
2+	112 [5]	5 [3]	117 [5]
Smoking history, no. [%]	1,672 [81]	150 [79]	1,821 [81]	0.43
Preop GFR, median [IQR]	61.3 [48.0-72.6]	60.7 [49.0-71.3]	61.2 [48.1-72.5]	0.80
Type of Diversion, no. [%]				0.08
Ileal Conduit	1,522 [77]	150 [82]	1,672 [77]
Neobladder	461 [23]	32 [18]	493 [23]
Operative time, min; median [IQR]	301 [255–355]	330 [262–365]	304 [256–356]	0.011
EBL, cc, median [IQR]	700 [450–1,000]	750 [500–1,100]	700 [450–1,000]	0.09
Perioperative chemotherapy, no. [%]	556 [27]	57 [30]	613 [27]	0.35
Preop BCG treatment, no. [%]	418 [20]	39 [20]	457 [20]	0.91
Pelvic radiation, no. [%]	256 [12]	28 [15]	284 [12]	0.34
Pathologic T-stage, no. [%]				0.12
<pT2	955 [46]	99 [52]	1,054 [46]
pT2	361 [17]	36 [19]	397 [18]
pT3/4	766 [37]	56 [29]	822 [36]
Pathologic N-stage, no. [%]				0.11
pN0/X	1,738 [84]	168 [88]	1,906 [84]
pN+	331 [16]	22 [12]	353 [16]
<30-day urine leak, no. [%]	78 [4]	11 [6]	89 [4]	0.18
<30-day UTI, no. [%; N=896]	61 [7]	11 [15]	72 [8]	0.02
<30-day abdominal abscess, no. [%]	52 [3]	1 [0]	53 [2]	0.08
Max Clavien ≥3, no. [%]	239 [11]	46 [24]	285 [13]	<0.0001

IQR, interquartile range; UES, ureteroenteric stricture; BMI, body mass index; BCG, Bacillus Calmette-Guerin; ECOG, Eastern Cooperative Oncology Group; EBL, estimated blood loss; GFR, glomerular filtration rate; UTI, urinary tract infection.